
North America Aortic Stent Graft Market Report and Forecast 2024-2032
Description
North America Aortic Stent Graft Market Report and Forecast 2024-2032
North America Aortic Stent Graft Market Report and Forecast 2024-2032
North America Aortic Stent Graft Market Outlook
The North America aortic stent graft market size was valued at USD 3.1 billion in 2023. It is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, driven by the growing geriatric population along with the advancements in stent graft materials and design in the region. It is estimated to reach a value of USD 5.2 billion by 2032.
Key Takeaways
- In the United States, ruptured abdominal aortic aneurysms are responsible for an estimated 15,000 deaths annually, ranking as the 13th leading cause of death in the region.
- In April 2023, Medtronic plc, declared positive results from a 10-year post-market ENGAGE registry for its Endurant stent graft system which provides endovascular aneurysm repair (EVAR) to treat the abdominal aortic aneurysm.
- In December 2023 , W. L. Gore & Associates, Inc. announced the first patient treatment with Gore ascending stent graft in the ARISE II study to treat pathologies involving the ascending aorta, marking an advancement in minimally invasive procedures.
The market is witnessing increased investment in research and development activities by the key market players in order to meet the growing demand for improved and safer aortic stent grafts. In April 2023, Medtronic plc, an American medical device company, announced positive results from a 10-year post-market ENGAGE registry for its Endurant stent graft system which provides endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysm. The data was presented at the 2023 Charing Cross Symposium in London, revealing 94.7% of cases reporting freedom from aneurysm-related mortality out of a pool of 400 patients. The presence of such real-world patient evidence is likely to boost the trust of patients and healthcare providers in the efficacy of aortic stent grafts, thereby fuelling North America aortic stent graft market growth.
In December 2023 , W. L. Gore & Associates, Inc., an American multinational material science company, announced the first patient treatment with Gore ascending stent graft to treat pathologies involving the ascending aorta. It was based on the results of ARISE II, a pivotal study by the United States Food and Drug Administration (FDA). The study marks an advancement in minimally invasive procedures by using endovascular repair rather than conventional open surgical repair. The development of such minimally invasive alternatives which can reduce recovery times as well as the risk of complications is likely to augment the North America aortic stent graft market size in the forecast period.
The market is also driven by the rising technological innovation in stent grafts, the increased accessibility to novel medical devices in healthcare settings, and the growing elderly population at a greater risk of developing aortic aneurysms. Moreover, the presence of an advanced infrastructure and heightened patient awareness in the region is expected to bolster the market growth in the forecast period.
North America Aortic Stent Graft Market Segmentation
“North America Aortic Stent Graft Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Abdominal Aortic Stent Grafts
- Thoracic Aortic stent Grafts
- Hospitals
- Ambulatory Surgical Centers
- Others
- United States of America
- Canada
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Medical, Inc.
- W.L. Gore & Associates
- MicroPort Scientific Corporation Inc.
- Medtronic Plc.
- Lombard Medical, Inc.
- Endologix, Inc.
- Terumo Corporation Inc.
- Cardinal Health Inc.
- Becton, Dickinson and Company
- Cryolife Inc.
FAQs
- What was the North America aortic stent graft market value in 2023?
- What is the North America aortic stent graft market forecast outlook for 2024-2032?
- What are the major factors aiding the North America aortic stent graft market demand?
- What are the major North America aortic stent graft market trends?
- What is the market segmentation based on the product?
- What are the major end users of aortic stent grafts in North America?
- What is the market segmentation by countries?
- Who are the key players involved in the North America aortic stent graft market?
Meta description
The North America aortic stent graft market size is anticipated to grow at a CAGR of 10.59% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
120 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 North America Aortic Stent Graft Market Overview
- 3.1 North America Aortic Stent Graft Market Historical Value (2017-2023)
- 3.2 North America Aortic Stent Graft Market Forecast Value (2024-2032)
- 4 North America Aortic Stent Graft Market Landscape*
- 4.1 North America Aortic Stent Graft: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 North America Aortic Stent Graft: Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Type
- 4.2.3 Analysis by Application
- 5 North America Aortic Stent Graft Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Analysis
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 North America Aortic Stent Graft Market Segmentation (2017-2032)
- 6.1 North America Aortic Stent Graft Market (2017-2032) by Product
- 6.1.1 Market Overview
- 6.1.2 Abdominal Aortic Stent Grafts
- 6.1.3 Thoracic Aortic stent Grafts
- 6.2 North America Aortic Stent Graft Market (2017-2032) by End User
- 6.2.1 Market Overview
- 6.2.2 Hospitals
- 6.2.3 Ambulatory Surgical Centers
- 6.2.4 Others
- 6.3 North America Aortic Stent Graft Market (2017-2032) by Countries
- 6.3.1 Market Overview
- 6.3.2 United States of America
- 6.3.3 Canada
- 7 United States of Aortic Stent Graft Market (2017-2032)
- 7.1 United State of Aortic Stent Graft Market (2017-2032) by Product
- 7.1.1 Market Overview
- 7.1.2 Abdominal Aortic Stent Grafts
- 7.1.3 Thoracic Aortic stent Grafts
- 7.2 United State of Aortic Stent Graft Market (2017-2032) by End User
- 7.2.1 Market Overview
- 7.2.2 Hospitals
- 7.2.3 Ambulatory Surgical Centers
- 7.2.4 Others
- 8 Canada Aortic Stent Graft Market (2017-2032)
- 8.1 Canada Aortic Stent Graft Market (2017-2032) by Product
- 8.1.1 Market Overview
- 8.1.2 Abdominal Aortic Stent Grafts
- 8.1.3 Thoracic Aortic stent Grafts
- 8.2 North America Aortic Stent Graft Market (2017-2032) by End User
- 8.2.1 Market Overview
- 8.2.2 Hospitals
- 8.2.3 Ambulatory Surgical Centers
- 8.2.4 Others
- 9 Regulatory Framework
- 10 Patent Analysis
- 10.1 Analysis by Type of Patent
- 10.2 Analysis by Publication year
- 10.3 Analysis by Issuing Authority
- 10.4 Analysis by Patent Age
- 10.5 Analysis by CPC Analysis
- 10.6 Analysis by Patent Valuation
- 10.7 Analysis by Key Players
- 11 Funding and Investment Analysis
- 11.1 Analysis by Funding Instances
- 11.2 Analysis by Type of Funding
- 11.3 Analysis by Funding Amount
- 11.4 Analysis by Leading Players
- 11.5 Analysis by Leading Investors
- 11.6 Analysis by Geography
- 12 Partnership and Collaborations Analysis
- 12.1 Analysis by Partnership Instances
- 12.2 Analysis by Type of Partnership
- 12.3 Analysis by Leading Players
- 12.4 Analysis by Geography
- 13 Supplier Landscape
- 13.1 Market Share by Top 5 Companies
- 13.2 Cook Medical, Inc.
- 13.2.1 Financial Analysis
- 13.2.2 Product Portfolio
- 13.2.3 Demographic Reach and Achievements
- 13.2.4 Mergers and Acquisitions
- 13.2.5 Certifications
- 13.3 W.l. Gore & Associates
- 13.3.1 Financial Analysis
- 13.3.2 Product Portfolio
- 13.3.3 Demographic Reach and Achievements
- 13.3.4 Mergers and Acquisitions
- 13.3.5 Certifications
- 13.4 MicroPort Scientific Corporation Inc.
- 13.4.1 Financial Analysis
- 13.4.2 Product Portfolio
- 13.4.3 Demographic Reach and Achievements
- 13.4.4 Mergers and Acquisitions
- 13.4.5 Certifications
- 13.5 Medtronic Plc.
- 13.5.1 Financial Analysis
- 13.5.2 Product Portfolio
- 13.5.3 Demographic Reach and Achievements
- 13.5.4 Mergers and Acquisitions
- 13.5.5 Certifications
- 13.6 Lombard Medical, Inc.
- 13.6.1 Financial Analysis
- 13.6.2 Product Portfolio
- 13.6.3 Demographic Reach and Achievements
- 13.6.4 Mergers and Acquisitions
- 13.6.5 Certifications
- 13.7 Endologix, INC.
- 13.7.1 Financial Analysis
- 13.7.2 Product Portfolio
- 13.7.3 Demographic Reach and Achievements
- 13.7.4 Mergers and Acquisitions
- 13.7.5 Certifications
- 13.8 Terumo Corporation Inc.
- 13.8.1 Financial Analysis
- 13.8.2 Product Portfolio
- 13.8.3 Demographic Reach and Achievements
- 13.8.4 Mergers and Acquisitions
- 13.8.5 Certifications
- 13.9 Cardinal Health Inc.
- 13.9.1 Financial Analysis
- 13.9.2 Product Portfolio
- 13.9.3 Demographic Reach and Achievements
- 13.9.4 Mergers and Acquisitions
- 13.9.5 Certifications
- 13.10 Becton, Dickinson and Company
- 13.10.1 Financial Analysis
- 13.10.2 Product Portfolio
- 13.10.3 Demographic Reach and Achievements
- 13.10.4 Mergers and Acquisitions
- 13.10.5 Certifications
- 13.11 Cryolife Inc.
- 13.11.1 Financial Analysis
- 13.11.2 Product Portfolio
- 13.11.3 Demographic Reach and Achievements
- 13.11.4 Mergers and Acquisitions
- 13.11.5 Certifications
- 14 United States of America Cannula Market – Distribution Model (Additional Insight)
- 14.1 Overview
- 14.2 Potential Distributors
- 14.3 Key Parameters for Distribution Partner Assessment
- 15 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 16 Company Competitiveness Analysis (Additional Insight)
- 16.1 Very Small Companies
- 16.2 Small Companies
- 16.3 Mid-Sized Companies
- 16.4 Large Companies
- 16.5 Very Large Companies
- 17 Payment Methods (Additional Insight)
- 17.1 Government Funded
- 17.2 Private Insurance
- 17.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.